Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)



Status:Active, not recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:28 - 31
Updated:1/25/2017
Start Date:September 2014
End Date:September 2018

Use our guide to learn which trials are right for you!

Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

This research study is designed to evaluate the effects of human umbilical cord mesenchymal
stem cells (UC-MSCs), on Duchenne's muscular dystrophy (DMD). The potential muscle
regenerative and anti-inflammatory properties of UC MSCs position them as a possible
treatment option for DMD. Both of these properties could lead to potential benefits for a
DMD patient.


Inclusion Criteria:

- Duchenne's Muscular Dystrophy

Exclusion Criteria:
We found this trial at
1
site
10021 West 21st Street North
Wichita, Kansas 67205
?
mi
from
Wichita, KS
Click here to add this to my saved trials